Non-Coding RNAs in Peritoneal Carcinomatosis: From Bench to Bedside

Author:

Bohosova Julia123,Ashraf Nida Sarosh14,Slaby Ondrej23,Calin George A.15ORCID

Affiliation:

1. Translational Molecular Pathology Department, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

2. Central European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic

3. Department of Biology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic

4. Cancer Genetics and Epigenetics Lab, Department of Biosciences, COMSATS University Islamabad, Islamabad 45550, Pakistan

5. The RNA Interference and Non-Coding RNA Center, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

Abstract

Peritoneal carcinomatosis represents an advanced stage of tumors within the peritoneal cavity. Once considered an incurable terminal cancer metastasis, contemporary medicine is on the hunt for certain potentially curative options alongside the present day’s palliative disease management. However, for most patients, peritoneal carcinomatosis continues to pose a fatal late-stage prognosis with a grim future outlook. Over the past two decades, non-coding RNAs have garnered significant attention due to their undeniable significance in regulating cellular processes across all levels. Disruption of the intricate regulation led by non-coding RNAs has been demonstrated to have a substantial impact on various human diseases, particularly in cancer, including solid tumors originating from the organs of the peritoneal cavity. This review aims to offer a comprehensive overview of the current state of knowledge in the under-researched field of peritoneal carcinomatosis, focusing specifically on the role of non-coding RNAs in the development of this condition and delineating potential avenues for future research.

Funder

European Union’s Horizon 2020 research and innovation program

Publisher

MDPI AG

Reference62 articles.

1. Desai, J.P., and Moustarah, F. (2023). Peritoneal Metastasis. StatPearls, StatPearls Publishing.

2. Implantation Peritoneal Carcinomatosis of Ovarian Origin;Sampson;Am. J. Pathol.,1931

3. Peritoneal Carcinomatosis: Limits of Diagnosis and the Case for Liquid Biopsy;McMullen;Oncotarget,2017

4. Intraperitoneal Therapy for Gastric Cancer Peritoneal Carcinomatosis;Harada;Expert Rev. Clin. Pharmacol.,2022

5. A Palliative Approach to Management of Peritoneal Carcinomatosis and Malignant Ascites;Bleicher;Surg. Oncol. Clin. N. Am.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3